

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of interleukin-12 production (GO:0032695) | 4.79259509 |
| 2 | response to peptidoglycan (GO:0032494) | 4.64028238 |
| 3 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.29917751 |
| 4 | glycosphingolipid catabolic process (GO:0046479) | 4.13616823 |
| 5 | regulation of mononuclear cell migration (GO:0071675) | 3.99339234 |
| 6 | macrophage activation involved in immune response (GO:0002281) | 3.92858597 |
| 7 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.92075567 |
| 8 | regulation of vitamin metabolic process (GO:0030656) | 3.84413417 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 3.83669482 |
| 10 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.83223759 |
| 11 | oligosaccharide catabolic process (GO:0009313) | 3.74309960 |
| 12 | glycolipid catabolic process (GO:0019377) | 3.72386125 |
| 13 | immunoglobulin mediated immune response (GO:0016064) | 3.71866423 |
| 14 | regulation of podosome assembly (GO:0071801) | 3.61789218 |
| 15 | T-helper 1 type immune response (GO:0042088) | 3.61735228 |
| 16 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.61528827 |
| 17 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.46065756 |
| 18 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.44420724 |
| 19 | modulation by symbiont of host immune response (GO:0052553) | 3.43846219 |
| 20 | positive regulation by symbiont of host defense response (GO:0052509) | 3.43846219 |
| 21 | modulation by symbiont of host defense response (GO:0052031) | 3.43846219 |
| 22 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.43846219 |
| 23 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.43846219 |
| 24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.43846219 |
| 25 | detection of molecule of bacterial origin (GO:0032490) | 3.39105636 |
| 26 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.38226547 |
| 27 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.37141544 |
| 28 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.30185850 |
| 29 | regulation of interferon-alpha production (GO:0032647) | 3.26116218 |
| 30 | myeloid dendritic cell differentiation (GO:0043011) | 3.25906334 |
| 31 | NIK/NF-kappaB signaling (GO:0038061) | 3.24732300 |
| 32 | ceramide catabolic process (GO:0046514) | 3.20817381 |
| 33 | adhesion of symbiont to host cell (GO:0044650) | 3.19237411 |
| 34 | virion attachment to host cell (GO:0019062) | 3.19237411 |
| 35 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.16139265 |
| 36 | monocyte chemotaxis (GO:0002548) | 3.14699104 |
| 37 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.11807878 |
| 38 | type I interferon signaling pathway (GO:0060337) | 3.10598320 |
| 39 | cellular response to type I interferon (GO:0071357) | 3.10598320 |
| 40 | germinal center formation (GO:0002467) | 3.10269763 |
| 41 | regulation of chronic inflammatory response (GO:0002676) | 3.08305461 |
| 42 | detection of other organism (GO:0098543) | 3.06370245 |
| 43 | response to type I interferon (GO:0034340) | 3.06337807 |
| 44 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.03491839 |
| 45 | regulation of chemokine biosynthetic process (GO:0045073) | 3.02428158 |
| 46 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.01798618 |
| 47 | membrane lipid catabolic process (GO:0046466) | 3.00772271 |
| 48 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.00098580 |
| 49 | regulation of cholesterol storage (GO:0010885) | 2.96356126 |
| 50 | adhesion of symbiont to host (GO:0044406) | 2.95156032 |
| 51 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.95104707 |
| 52 | regulation of macrophage chemotaxis (GO:0010758) | 2.93619841 |
| 53 | detection of external biotic stimulus (GO:0098581) | 2.91924356 |
| 54 | angiotensin maturation (GO:0002003) | 2.91216991 |
| 55 | granulocyte activation (GO:0036230) | 2.89892557 |
| 56 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.88976181 |
| 57 | positive regulation of type 2 immune response (GO:0002830) | 2.88825524 |
| 58 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.87880266 |
| 59 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.87410404 |
| 60 | sphingolipid catabolic process (GO:0030149) | 2.87043429 |
| 61 | positive regulation of heat generation (GO:0031652) | 2.86329340 |
| 62 | myeloid dendritic cell activation (GO:0001773) | 2.84860581 |
| 63 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.82593988 |
| 64 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.81999376 |
| 65 | response to thyroid hormone (GO:0097066) | 2.81717676 |
| 66 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.80476353 |
| 67 | defense response to protozoan (GO:0042832) | 2.80322547 |
| 68 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.79890964 |
| 69 | response to protozoan (GO:0001562) | 2.79119166 |
| 70 | regulation of fever generation (GO:0031620) | 2.78307304 |
| 71 | positive regulation of interferon-alpha production (GO:0032727) | 2.77753866 |
| 72 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.76700476 |
| 73 | B cell mediated immunity (GO:0019724) | 2.76269484 |
| 74 | cellular response to lipopolysaccharide (GO:0071222) | 2.75896948 |
| 75 | detection of bacterium (GO:0016045) | 2.75709365 |
| 76 | eosinophil chemotaxis (GO:0048245) | 2.74455977 |
| 77 | amino sugar catabolic process (GO:0046348) | 2.72515303 |
| 78 | low-density lipoprotein particle clearance (GO:0034383) | 2.71268761 |
| 79 | positive regulation of antigen processing and presentation (GO:0002579) | 2.71047277 |
| 80 | macrophage activation (GO:0042116) | 2.70905150 |
| 81 | cellular response to molecule of bacterial origin (GO:0071219) | 2.70030832 |
| 82 | negative regulation of cell killing (GO:0031342) | 2.69626594 |
| 83 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.69626594 |
| 84 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.68656312 |
| 85 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.68398141 |
| 86 | regulation of antigen processing and presentation (GO:0002577) | 2.67743846 |
| 87 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.67420164 |
| 88 | regulation of interleukin-12 production (GO:0032655) | 2.66822698 |
| 89 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.65967517 |
| 90 | cellular extravasation (GO:0045123) | 2.65802893 |
| 91 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.64859914 |
| 92 | dendritic cell differentiation (GO:0097028) | 2.62923899 |
| 93 | regulation of mast cell degranulation (GO:0043304) | 2.61924964 |
| 94 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.61366182 |
| 95 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.60500083 |
| 96 | detection of biotic stimulus (GO:0009595) | 2.60333848 |
| 97 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.58036879 |
| 98 | myeloid cell activation involved in immune response (GO:0002275) | 2.57604143 |
| 99 | regulation of T cell tolerance induction (GO:0002664) | 2.57331121 |
| 100 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.57263062 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.76064080 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.16622175 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.73225142 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.61891235 |
| 5 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.37368074 |
| 6 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.37195076 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.35491592 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.20485588 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.07166804 |
| 10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.05598862 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.72032722 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.43661626 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.40318594 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.32669707 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.29410012 |
| 16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.26644486 |
| 17 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.21855912 |
| 18 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.19709075 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.18832801 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.09644098 |
| 21 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.01247217 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.98877901 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.93864820 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.93738357 |
| 25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.92338628 |
| 26 | SPI1_23127762_ChIP-Seq_K562_Human | 1.86370285 |
| 27 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.85263655 |
| 28 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.76894815 |
| 29 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.76711137 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.73865137 |
| 31 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.69483558 |
| 32 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.66288671 |
| 33 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.64990872 |
| 34 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.63680354 |
| 35 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.63144403 |
| 36 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.61896978 |
| 37 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.60785839 |
| 38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60371800 |
| 39 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.51898230 |
| 40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.48930446 |
| 41 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.48928368 |
| 42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.44274041 |
| 43 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.41171795 |
| 44 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.39686893 |
| 45 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.36653615 |
| 46 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35413917 |
| 47 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.35246096 |
| 48 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.34751334 |
| 49 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.34405676 |
| 50 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.32821734 |
| 51 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.32156494 |
| 52 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.30313131 |
| 53 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28688538 |
| 54 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28043933 |
| 55 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22706326 |
| 56 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21909462 |
| 57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.21016690 |
| 58 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.20236423 |
| 59 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17387955 |
| 60 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.15633608 |
| 61 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15425770 |
| 62 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15401890 |
| 63 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13890971 |
| 64 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.13367070 |
| 65 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.12802674 |
| 66 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12783210 |
| 67 | MAF_26560356_Chip-Seq_TH1_Human | 1.09851635 |
| 68 | MYB_26560356_Chip-Seq_TH2_Human | 1.09651915 |
| 69 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09316377 |
| 70 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08809666 |
| 71 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08379180 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07094796 |
| 73 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.06991570 |
| 74 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.06246237 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05474368 |
| 76 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.01421691 |
| 77 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.98669382 |
| 78 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.97023796 |
| 79 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.95695548 |
| 80 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.95253805 |
| 81 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.95253805 |
| 82 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.95253805 |
| 83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.94851468 |
| 84 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.94192833 |
| 85 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93857000 |
| 86 | MYB_26560356_Chip-Seq_TH1_Human | 0.91398622 |
| 87 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91350982 |
| 88 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.90949107 |
| 89 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.90433474 |
| 90 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.87941994 |
| 91 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.87808792 |
| 92 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.83798056 |
| 93 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.83788946 |
| 94 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.83684043 |
| 95 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83505929 |
| 96 | UTX_26944678_Chip-Seq_JUKART_Human | 0.83043088 |
| 97 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82914974 |
| 98 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.82661611 |
| 99 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.82228245 |
| 100 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.81879820 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.34638784 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.75944959 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.73640736 |
| 4 | MP0009840_abnormal_foam_cell | 3.53466596 |
| 5 | MP0006082_CNS_inflammation | 3.17659273 |
| 6 | MP0003724_increased_susceptibility_to | 3.13214138 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 3.04066847 |
| 8 | MP0009785_altered_susceptibility_to | 2.94874937 |
| 9 | MP0003436_decreased_susceptibility_to | 2.91812235 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.55543494 |
| 11 | MP0002419_abnormal_innate_immunity | 2.45972478 |
| 12 | MP0005671_abnormal_response_to | 2.37965239 |
| 13 | MP0003300_gastrointestinal_ulcer | 2.33226824 |
| 14 | MP0004510_myositis | 2.33134759 |
| 15 | MP0005387_immune_system_phenotype | 2.31226773 |
| 16 | MP0001790_abnormal_immune_system | 2.31226773 |
| 17 | MP0005025_abnormal_response_to | 2.24837291 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.21840282 |
| 19 | MP0005000_abnormal_immune_tolerance | 2.21020601 |
| 20 | MP0005451_abnormal_body_composition | 2.20356953 |
| 21 | MP0003806_abnormal_nucleotide_metabolis | 2.19879512 |
| 22 | MP0003075_altered_response_to | 2.09852582 |
| 23 | MP0008004_abnormal_stomach_pH | 2.03993074 |
| 24 | MP0003172_abnormal_lysosome_physiology | 1.99742274 |
| 25 | MP0009764_decreased_sensitivity_to | 1.99155817 |
| 26 | MP0000343_altered_response_to | 1.97046123 |
| 27 | MP0000604_amyloidosis | 1.94936499 |
| 28 | MP0003195_calcinosis | 1.93028841 |
| 29 | MP0002452_abnormal_antigen_presenting | 1.87682972 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.82213677 |
| 31 | MP0002723_abnormal_immune_serum | 1.79420548 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.74544891 |
| 33 | MP0001853_heart_inflammation | 1.73319319 |
| 34 | MP0001800_abnormal_humoral_immune | 1.73249791 |
| 35 | MP0005365_abnormal_bile_salt | 1.71570803 |
| 36 | MP0002254_reproductive_system_inflammat | 1.71226621 |
| 37 | MP0004947_skin_inflammation | 1.70947864 |
| 38 | MP0006054_spinal_hemorrhage | 1.70129333 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.69531352 |
| 40 | MP0000685_abnormal_immune_system | 1.63839639 |
| 41 | MP0008469_abnormal_protein_level | 1.63459380 |
| 42 | MP0002138_abnormal_hepatobiliary_system | 1.62842420 |
| 43 | MP0002998_abnormal_bone_remodeling | 1.61613141 |
| 44 | MP0005360_urolithiasis | 1.61575949 |
| 45 | MP0003453_abnormal_keratinocyte_physiol | 1.56811622 |
| 46 | MP0001819_abnormal_immune_cell | 1.48697828 |
| 47 | MP0002420_abnormal_adaptive_immunity | 1.48295706 |
| 48 | MP0005166_decreased_susceptibility_to | 1.46335140 |
| 49 | MP0003183_abnormal_peptide_metabolism | 1.40721334 |
| 50 | MP0003448_altered_tumor_morphology | 1.39056248 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.37047338 |
| 52 | MP0009278_abnormal_bone_marrow | 1.36263654 |
| 53 | MP0002405_respiratory_system_inflammati | 1.34261189 |
| 54 | MP0005167_abnormal_blood-brain_barrier | 1.32578388 |
| 55 | MP0005310_abnormal_salivary_gland | 1.32294124 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.31733552 |
| 57 | MP0003690_abnormal_glial_cell | 1.27539988 |
| 58 | MP0005397_hematopoietic_system_phenotyp | 1.25321293 |
| 59 | MP0001545_abnormal_hematopoietic_system | 1.25321293 |
| 60 | MP0002332_abnormal_exercise_endurance | 1.21404001 |
| 61 | MP0000858_altered_metastatic_potential | 1.19867913 |
| 62 | MP0008260_abnormal_autophagy | 1.19252370 |
| 63 | MP0005085_abnormal_gallbladder_physiolo | 1.13333348 |
| 64 | MP0000716_abnormal_immune_system | 1.02388346 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 1.01479344 |
| 66 | MP0005164_abnormal_response_to | 0.97000304 |
| 67 | MP0004019_abnormal_vitamin_homeostasis | 0.93843366 |
| 68 | MP0003828_pulmonary_edema | 0.91353579 |
| 69 | MP0003329_amyloid_beta_deposits | 0.90707208 |
| 70 | MP0003091_abnormal_cell_migration | 0.89921412 |
| 71 | MP0001666_abnormal_nutrient_absorption | 0.88657336 |
| 72 | MP0005319_abnormal_enzyme/_coenzyme | 0.88297625 |
| 73 | MP0009763_increased_sensitivity_to | 0.87813627 |
| 74 | MP0005165_increased_susceptibility_to | 0.87801563 |
| 75 | MP0005647_abnormal_sex_gland | 0.87640561 |
| 76 | MP0000609_abnormal_liver_physiology | 0.85279999 |
| 77 | MP0000920_abnormal_myelination | 0.84592324 |
| 78 | MP0010234_abnormal_vibrissa_follicle | 0.80370909 |
| 79 | MP0004883_abnormal_blood_vessel | 0.77611789 |
| 80 | MP0002429_abnormal_blood_cell | 0.76459667 |
| 81 | MP0001764_abnormal_homeostasis | 0.76111803 |
| 82 | MP0002398_abnormal_bone_marrow | 0.74850540 |
| 83 | MP0000689_abnormal_spleen_morphology | 0.74570654 |
| 84 | MP0005410_abnormal_fertilization | 0.74425400 |
| 85 | MP0000465_gastrointestinal_hemorrhage | 0.73209144 |
| 86 | MP0000249_abnormal_blood_vessel | 0.72359040 |
| 87 | MP0005076_abnormal_cell_differentiation | 0.72299284 |
| 88 | MP0005023_abnormal_wound_healing | 0.72276181 |
| 89 | MP0002722_abnormal_immune_system | 0.69017750 |
| 90 | MP0001663_abnormal_digestive_system | 0.69014086 |
| 91 | MP0009765_abnormal_xenobiotic_induced | 0.67983832 |
| 92 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.67593126 |
| 93 | MP0005390_skeleton_phenotype | 0.66505789 |
| 94 | MP0002877_abnormal_melanocyte_morpholog | 0.66188634 |
| 95 | MP0008874_decreased_physiological_sensi | 0.65619448 |
| 96 | MP0010307_abnormal_tumor_latency | 0.64144616 |
| 97 | MP0008875_abnormal_xenobiotic_pharmacok | 0.63719646 |
| 98 | MP0001542_abnormal_bone_strength | 0.62959789 |
| 99 | MP0002118_abnormal_lipid_homeostasis | 0.62634924 |
| 100 | MP0009115_abnormal_fat_cell | 0.61246497 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.70717275 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.70717275 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 6.70717275 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 5.46811751 |
| 5 | Vacuolated lymphocytes (HP:0001922) | 5.09661471 |
| 6 | Abnormality of macrophages (HP:0004311) | 5.06059390 |
| 7 | Increased cerebral lipofuscin (HP:0011813) | 4.62847696 |
| 8 | Eczematoid dermatitis (HP:0000976) | 4.32317901 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 4.23835538 |
| 10 | Recurrent abscess formation (HP:0002722) | 4.14581954 |
| 11 | Loss of speech (HP:0002371) | 4.11496850 |
| 12 | Dysostosis multiplex (HP:0000943) | 4.03944378 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.95188579 |
| 14 | Disinhibition (HP:0000734) | 3.90950736 |
| 15 | Orchitis (HP:0100796) | 3.86608446 |
| 16 | Retrobulbar optic neuritis (HP:0100654) | 3.74501746 |
| 17 | Optic neuritis (HP:0100653) | 3.74501746 |
| 18 | Glomerulonephritis (HP:0000099) | 3.74167514 |
| 19 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.72519912 |
| 20 | Myositis (HP:0100614) | 3.48200541 |
| 21 | Myocardial infarction (HP:0001658) | 3.44410530 |
| 22 | Mutism (HP:0002300) | 3.24507132 |
| 23 | Stomatitis (HP:0010280) | 3.22887307 |
| 24 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.22531164 |
| 25 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.22531164 |
| 26 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.22531164 |
| 27 | Complement deficiency (HP:0004431) | 3.21508101 |
| 28 | Mediastinal lymphadenopathy (HP:0100721) | 3.18065864 |
| 29 | Autoimmune thrombocytopenia (HP:0001973) | 3.15977175 |
| 30 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.11666894 |
| 31 | Mucopolysacchariduria (HP:0008155) | 3.11666894 |
| 32 | Axonal loss (HP:0003447) | 3.06574967 |
| 33 | Malnutrition (HP:0004395) | 2.98285962 |
| 34 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.89817084 |
| 35 | Amyloidosis (HP:0011034) | 2.84449234 |
| 36 | Neurofibrillary tangles (HP:0002185) | 2.81947363 |
| 37 | Increased serum ferritin (HP:0003281) | 2.79490185 |
| 38 | Nuclear cataract (HP:0100018) | 2.71610862 |
| 39 | Abnormality of complement system (HP:0005339) | 2.67020050 |
| 40 | Keratoconjunctivitis sicca (HP:0001097) | 2.59508009 |
| 41 | Nausea (HP:0002018) | 2.58822556 |
| 42 | Purpura (HP:0000979) | 2.55625631 |
| 43 | Gingivitis (HP:0000230) | 2.53213059 |
| 44 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.49830044 |
| 45 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.49509583 |
| 46 | Metaphyseal irregularity (HP:0003025) | 2.48209367 |
| 47 | Pulmonary infiltrates (HP:0002113) | 2.43259013 |
| 48 | Recurrent skin infections (HP:0001581) | 2.42830232 |
| 49 | Hematochezia (HP:0002573) | 2.40975508 |
| 50 | Gangrene (HP:0100758) | 2.38280824 |
| 51 | Apathy (HP:0000741) | 2.37974176 |
| 52 | Diminished motivation (HP:0000745) | 2.33005660 |
| 53 | Obstructive lung disease (HP:0006536) | 2.31124918 |
| 54 | Chronic obstructive pulmonary disease (HP:0006510) | 2.31124918 |
| 55 | Increased IgM level (HP:0003496) | 2.30321438 |
| 56 | Keratoconjunctivitis (HP:0001096) | 2.29388593 |
| 57 | Vasculitis (HP:0002633) | 2.27449004 |
| 58 | Progressive neurologic deterioration (HP:0002344) | 2.26525055 |
| 59 | Interstitial pulmonary disease (HP:0006530) | 2.25847551 |
| 60 | Hemoptysis (HP:0002105) | 2.22308218 |
| 61 | Polyneuropathy (HP:0001271) | 2.21869280 |
| 62 | Abnormality of iron homeostasis (HP:0011031) | 2.21257818 |
| 63 | Agnosia (HP:0010524) | 2.19182138 |
| 64 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.16917253 |
| 65 | Asymmetric septal hypertrophy (HP:0001670) | 2.16768952 |
| 66 | Xanthomatosis (HP:0000991) | 2.16049637 |
| 67 | Nephritis (HP:0000123) | 2.13820547 |
| 68 | Thin bony cortex (HP:0002753) | 2.12138948 |
| 69 | Deep venous thrombosis (HP:0002625) | 2.11354642 |
| 70 | Hepatosplenomegaly (HP:0001433) | 2.10050630 |
| 71 | Intrahepatic cholestasis (HP:0001406) | 2.07880316 |
| 72 | Neuronal loss in central nervous system (HP:0002529) | 2.06636564 |
| 73 | Peripheral demyelination (HP:0011096) | 2.06105228 |
| 74 | Recurrent fungal infections (HP:0002841) | 2.05308857 |
| 75 | Cerebral inclusion bodies (HP:0100314) | 2.05240349 |
| 76 | Upper motor neuron abnormality (HP:0002127) | 2.04158405 |
| 77 | Pathologic fracture (HP:0002756) | 2.01821217 |
| 78 | Bone pain (HP:0002653) | 2.00438560 |
| 79 | Petechiae (HP:0000967) | 2.00038008 |
| 80 | Thoracic kyphosis (HP:0002942) | 1.99765355 |
| 81 | Esophageal varix (HP:0002040) | 1.99566816 |
| 82 | Dementia (HP:0000726) | 1.96406633 |
| 83 | Prolonged neonatal jaundice (HP:0006579) | 1.95778953 |
| 84 | Spontaneous hematomas (HP:0007420) | 1.93098790 |
| 85 | Inappropriate behavior (HP:0000719) | 1.92170665 |
| 86 | Pulmonary embolism (HP:0002204) | 1.92126049 |
| 87 | T lymphocytopenia (HP:0005403) | 1.91581471 |
| 88 | Urticaria (HP:0001025) | 1.90949100 |
| 89 | Arterial thrombosis (HP:0004420) | 1.90161626 |
| 90 | Basal ganglia calcification (HP:0002135) | 1.88901873 |
| 91 | Retinal atrophy (HP:0001105) | 1.87842159 |
| 92 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.86621639 |
| 93 | Meningitis (HP:0001287) | 1.86321568 |
| 94 | Anorexia (HP:0002039) | 1.86078418 |
| 95 | Protuberant abdomen (HP:0001538) | 1.85815469 |
| 96 | Hypophosphatemia (HP:0002148) | 1.82471010 |
| 97 | Recurrent viral infections (HP:0004429) | 1.82432462 |
| 98 | Abnormality of T cell number (HP:0011839) | 1.82102298 |
| 99 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.80936158 |
| 100 | Encephalitis (HP:0002383) | 1.77877228 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 4.61372796 |
| 2 | NME2 | 3.55133543 |
| 3 | GRK7 | 3.16506355 |
| 4 | MAP3K14 | 3.06049270 |
| 5 | BLK | 2.69578484 |
| 6 | ACVR1B | 2.62347952 |
| 7 | DDR2 | 2.60192026 |
| 8 | RIPK4 | 2.53842494 |
| 9 | TYK2 | 2.53600346 |
| 10 | PRPF4B | 2.46695244 |
| 11 | TBK1 | 2.43255210 |
| 12 | MATK | 2.39915577 |
| 13 | TAOK2 | 2.38004253 |
| 14 | TGFBR2 | 2.34728593 |
| 15 | CSK | 2.14801984 |
| 16 | RIPK1 | 2.14515820 |
| 17 | FGR | 2.12576073 |
| 18 | MAP3K3 | 2.12424779 |
| 19 | ERN1 | 2.12112644 |
| 20 | MOS | 2.07109774 |
| 21 | IRAK4 | 1.98799724 |
| 22 | IKBKB | 1.71804057 |
| 23 | IKBKE | 1.70385439 |
| 24 | MAP3K13 | 1.69518601 |
| 25 | MAP2K3 | 1.57632636 |
| 26 | MAP4K1 | 1.57527835 |
| 27 | MAP3K11 | 1.52932658 |
| 28 | TAOK1 | 1.46270229 |
| 29 | CDC42BPA | 1.45881172 |
| 30 | TXK | 1.44420863 |
| 31 | MAP3K1 | 1.38149297 |
| 32 | JAK3 | 1.36294756 |
| 33 | ZAP70 | 1.36011292 |
| 34 | MARK3 | 1.26629771 |
| 35 | LATS2 | 1.20526853 |
| 36 | PIM2 | 1.20481639 |
| 37 | JAK1 | 1.18558486 |
| 38 | CSF1R | 1.14826259 |
| 39 | BMPR2 | 1.12964649 |
| 40 | ABL2 | 1.11803455 |
| 41 | IRAK2 | 1.06847078 |
| 42 | CHUK | 1.05165329 |
| 43 | STK10 | 1.04266839 |
| 44 | JAK2 | 1.02409619 |
| 45 | MAP3K5 | 1.00651862 |
| 46 | ADRBK2 | 1.00457944 |
| 47 | ARAF | 0.92466197 |
| 48 | IRAK1 | 0.91887654 |
| 49 | TESK2 | 0.90980570 |
| 50 | PDPK1 | 0.87384485 |
| 51 | LYN | 0.85685678 |
| 52 | SYK | 0.72678233 |
| 53 | NEK9 | 0.71532281 |
| 54 | TESK1 | 0.71302668 |
| 55 | TYRO3 | 0.67629492 |
| 56 | PAK4 | 0.67445550 |
| 57 | PDK2 | 0.66926893 |
| 58 | PDK1 | 0.66604141 |
| 59 | KSR2 | 0.65537162 |
| 60 | PIM1 | 0.65388771 |
| 61 | LCK | 0.64285903 |
| 62 | FGFR4 | 0.63112977 |
| 63 | HCK | 0.61452810 |
| 64 | SIK3 | 0.58946767 |
| 65 | FES | 0.58643598 |
| 66 | MELK | 0.57472755 |
| 67 | EPHB1 | 0.57174238 |
| 68 | CDK6 | 0.57166500 |
| 69 | PRKG2 | 0.55055883 |
| 70 | BTK | 0.54346588 |
| 71 | CLK1 | 0.47844481 |
| 72 | CAMKK2 | 0.46337302 |
| 73 | TRIB3 | 0.46083149 |
| 74 | CAMK1D | 0.45861493 |
| 75 | SIK1 | 0.44541854 |
| 76 | PDGFRA | 0.44148852 |
| 77 | MST1R | 0.42517897 |
| 78 | MAP3K8 | 0.41542851 |
| 79 | PRKAA2 | 0.35125828 |
| 80 | BMX | 0.34934430 |
| 81 | MAP3K9 | 0.32954736 |
| 82 | MAP3K2 | 0.32761329 |
| 83 | MAPKAPK2 | 0.32686022 |
| 84 | ABL1 | 0.31979257 |
| 85 | KIT | 0.31763134 |
| 86 | DAPK2 | 0.30290848 |
| 87 | EGFR | 0.29731842 |
| 88 | RPS6KC1 | 0.29201180 |
| 89 | RPS6KL1 | 0.29201180 |
| 90 | MAP2K6 | 0.29078202 |
| 91 | NLK | 0.28975257 |
| 92 | MAPK7 | 0.26969482 |
| 93 | ICK | 0.26687608 |
| 94 | MAPK4 | 0.25607410 |
| 95 | DYRK3 | 0.24175333 |
| 96 | RPS6KA2 | 0.23740117 |
| 97 | FGFR3 | 0.23695236 |
| 98 | STK24 | 0.21964142 |
| 99 | EPHA3 | 0.21455124 |
| 100 | GSK3A | 0.21396875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.25961079 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.12084428 |
| 3 | Lysosome_Homo sapiens_hsa04142 | 2.67545885 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.55755011 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.52067375 |
| 6 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.45562517 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.40734037 |
| 8 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.37404862 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.28717012 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.12267833 |
| 11 | Asthma_Homo sapiens_hsa05310 | 2.10505831 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 2.04246310 |
| 13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.01560952 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 1.97216224 |
| 15 | Malaria_Homo sapiens_hsa05144 | 1.95816379 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.91386634 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.89381298 |
| 18 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.85667732 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.84081479 |
| 20 | Legionellosis_Homo sapiens_hsa05134 | 1.83798271 |
| 21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.82451113 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.77977593 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.74698612 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.64938845 |
| 25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.53065910 |
| 26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.51334777 |
| 27 | Phagosome_Homo sapiens_hsa04145 | 1.45392646 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.43206287 |
| 29 | Salmonella infection_Homo sapiens_hsa05132 | 1.38713182 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.38094780 |
| 31 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.35574276 |
| 32 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.31797054 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.30078422 |
| 34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.27730599 |
| 35 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.19799642 |
| 36 | Prion diseases_Homo sapiens_hsa05020 | 1.18257921 |
| 37 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.15515039 |
| 38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.14797520 |
| 39 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.09740903 |
| 40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08634072 |
| 41 | Mineral absorption_Homo sapiens_hsa04978 | 1.08537728 |
| 42 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.05669848 |
| 43 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.02783325 |
| 44 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.02500777 |
| 45 | Hepatitis C_Homo sapiens_hsa05160 | 1.02005184 |
| 46 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.01030751 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.00951979 |
| 48 | Measles_Homo sapiens_hsa05162 | 0.99681301 |
| 49 | Galactose metabolism_Homo sapiens_hsa00052 | 0.99246624 |
| 50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.98580916 |
| 51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90320101 |
| 52 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.89316724 |
| 53 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.88819903 |
| 54 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.88172483 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.87883643 |
| 56 | Apoptosis_Homo sapiens_hsa04210 | 0.85936151 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84627128 |
| 58 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.82994937 |
| 59 | Amoebiasis_Homo sapiens_hsa05146 | 0.80971471 |
| 60 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.80758192 |
| 61 | Hepatitis B_Homo sapiens_hsa05161 | 0.77763614 |
| 62 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.76120157 |
| 63 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.75900762 |
| 64 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.71660374 |
| 65 | Shigellosis_Homo sapiens_hsa05131 | 0.71629174 |
| 66 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.71058903 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.68953184 |
| 68 | Bladder cancer_Homo sapiens_hsa05219 | 0.64203666 |
| 69 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.61657956 |
| 70 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.59006227 |
| 71 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.57746666 |
| 72 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.56213727 |
| 73 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.56019914 |
| 74 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.52687801 |
| 75 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.52448197 |
| 76 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.52422797 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50384990 |
| 78 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.50130624 |
| 79 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.45018118 |
| 80 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44469610 |
| 81 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.43012462 |
| 82 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.41761317 |
| 83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40498444 |
| 84 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.39165943 |
| 85 | Histidine metabolism_Homo sapiens_hsa00340 | 0.38935513 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.38819353 |
| 87 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.37859018 |
| 88 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.36987278 |
| 89 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.36155909 |
| 90 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35402701 |
| 91 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.35084698 |
| 92 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.31124020 |
| 93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30765396 |
| 94 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.30041287 |
| 95 | Bile secretion_Homo sapiens_hsa04976 | 0.27654106 |
| 96 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.27248796 |
| 97 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.26788888 |
| 98 | Retinol metabolism_Homo sapiens_hsa00830 | 0.26628833 |
| 99 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.25363495 |
| 100 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.24617167 |

